US House reform bill would increase Medicare Part D premiums but lower drug costs
01 September 2009
Sue Sutter
Pharmaceutical manufacturers would likely charge higher prices for new drugs and reduce rebates paid to Medicare Part D prescription drug plans, leading to higher premiums for beneficiaries, if the provisions of a US House healthcare reform bill were signed into law, the Congressional Budget Office...
Please Login to read the full article.
01 September 2009
Sue Sutter
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: Will pharma get fried in the debt ceiling chicken game?
- US Capitol Capsule: White House warns FDA budget cuts would severely limit agency
- US Capitol Capsule: Federal shutdown averted, but spending reductions could spell trouble for expensive drugs
- US Capitol Capsule: Use of mind-altering medicines in children, elderly under fire
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
